介入性心臟病器材市场规模、份额及成长分析（按产品、最终用户及地区划分）－2026-2033年产业预测

预计到 2024 年，介入性心臟病学设备市场规模将达到 148.6 亿美元，到 2025 年将达到 159.5 亿美元，到 2033 年将达到 280.2 亿美元，预测期（2026-2033 年）的复合年增长率为 7.3%。

由于创新心血管技术的进步和监管流程的简化，介入性心臟病器材市场正经历显着成长。介入性心臟科医师专注于使用导管——一种用于微创手术（如血管成形术和支架置入术）的柔性管——为传统手术提供有效的替代方案。这些器械主要用于治疗由高血压和糖尿病等疾病引起的心臟疾病，以及可能导致动脉斑块积聚的周边血管问题。现有器材包括导管、球囊、支架和滤器，体现了介入技术的多样性。然而，严格的政府监管和核准流程给市场带来了挑战，并可能阻碍其扩张。总体而言，在技术进步和患者接受度提高的推动下，该领域预计将持续成长。

介入性心臟病器材市场驱动因素

饱和脂肪酸摄取量增加、盐摄取过量、饮酒和吸烟等不健康的生活习惯是导致冠状动脉疾病风险上升的重要因素，预计这将推动介入性心臟病器材市场的成长。此外，吸烟率高且久坐的生活方式也进一步促进了市场扩张，因为缺乏体能活动与肥胖率上升和其他心血管疾病风险增加密切相关。这些因素共同凸显了对能够有效应对日益严重的冠状动脉疾病负担的先进介入性心臟病器械的迫切需求。

介入性心臟病器材市场限制因素

介入性心臟病器材市场面临许多限制因素，包括不断变化的客户需求和复杂的医疗设备认证监管要求。由于涉及诸多法律问题，应对这些法规结构可能极具挑战性。为确保医疗设备的性能和质量，需要进行全面的评估以保障公众安全。因此，医疗设备严格的多方面认证标准可能会阻碍市场扩张和创新。这种复杂性为製造商设置了障碍，使其难以推出新产品和新技术，最终影响该行业的市场动态和成长潜力。

介入性心臟病器材市场趋势

由于肥胖和不健康的生活方式导致心血管疾病盛行率不断上升，介入性心臟病学器械市场正经历显着增长。吸烟、过量饮酒和缺乏运动等因素导致冠状动脉疾病发生率不断攀升，推动了对先进介入治疗方案的需求。这些器械使心臟科医生能够进行微创手术，从而改善患者预后并减少併发症。对快速有效治疗方案的关注正在推动器材技术的创新，随着医疗保健系统优先考虑高效的心血管护理以应对日益严重的心臟疾病负担，预计该市场将强劲扩张。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 监管环境
• 案例研究
• 客户和购买标准分析
• 贸易分析
• 原料分析

全球介入性心臟病器材市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 冠状动脉支架
  • 裸金属支架（BMS）
  • 药物释放型支架（DES）
  • 其他的
• 结构性心臟装置
  • 心臟瓣膜
  • 闭合装置及其他
• 血管成形球囊
• 导管
  • 诊断导管
  • 血管造影术
  • IVUS
  • 治疗性导管
  • 动脉粥状硬化斑块切除术
  • 血栓切除术
  • 消融
• 栓塞保护装置

全球介入性心臟病器材市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院及门诊手术中心
• 导管检查室及其他

全球介入性心臟病器材市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Abbott Laboratories
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Medtronic PLC
• Terumo Corporation
• Biotronik SE & Co. KG
• Biosensors International Group Ltd
• ACIST Medical Systems
• Cardinal Health, Inc.
• Cook Medical Inc.
• Koninklijke Philips NV
• Edwards Lifesciences Corporation
• Nano Therapeutics Pvt. Ltd.
• AngioDynamics, Inc.
• Inari Medical, Inc.
• Genetesis, Inc.
• OptiMed Medical Instruments GmbH
• Meril Life Sciences Pvt. Ltd.
• OrbusNeich Medical

结论与建议

Interventional Cardiology Devices Market size was valued at USD 14.86 Billion in 2024 and is poised to grow from USD 15.95 Billion in 2025 to USD 28.02 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The interventional cardiology devices market is experiencing significant growth, driven by advancements in innovative cardiovascular technologies and streamlined regulatory processes. Interventional cardiologists specialize in using catheters-flexible tubes essential for minimally invasive procedures like angioplasty and stenting, offering viable alternatives to traditional surgeries. These devices primarily address heart ailments caused by conditions such as hypertension and diabetes while also catering to peripheral vascular issues that can lead to arterial plaque buildup. Available devices include catheters, balloons, stents, and filters, underscoring the versatility of interventional techniques. However, the market faces challenges from stringent government regulations and approval processes, which could potentially hinder its expansion. Overall, the sector is poised for growth, bolstered by technological advancements and increasing patient acceptance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Interventional Cardiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Interventional Cardiology Devices Market Segments Analysis

Global Interventional Cardiology Devices Market is segmented by product, end user and region. Based on product, the market is segmented intocoronary stents, structural heart devices, angioplasty balloons, catheters and embolic protection devices. Based on end user, the market is segmented into hospitals & ASCS and catheterization labs & others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Interventional Cardiology Devices Market

The rising prevalence of unhealthy lifestyle habits, such as the consumption of saturated fats, excessive salt, alcohol use, and smoking, is significantly contributing to an elevated risk of coronary artery disease, which, in turn, is expected to drive growth in the interventional cardiology devices market. Additionally, high rates of tobacco use and a sedentary lifestyle are further propelling market expansion, as physical inactivity is linked to increased obesity rates and further cardiovascular health issues. The combination of these factors underscores the urgent need for advanced interventional cardiology devices that can address the growing burden of coronary artery disease effectively.

Restraints in the Interventional Cardiology Devices Market

The Interventional Cardiology Devices market faces significant constraints due to evolving customer demands coupled with intricate regulatory requirements for medical device approval. Navigating these regulatory frameworks can be challenging due to the various legal considerations involved. Ensuring the performance and quality of medical devices necessitates thorough evaluation to protect public safety. Consequently, the rigorous and multifaceted certification standards imposed on medical devices may hinder the market's expansion and innovation. These complexities create barriers for manufacturers, making it difficult to introduce new products and advancements, ultimately impacting market dynamics and growth potential in the sector.

Market Trends of the Interventional Cardiology Devices Market

The Interventional Cardiology Devices market is witnessing significant growth, propelled by the rising prevalence of cardiovascular diseases linked to obesity and unhealthy lifestyle choices. As coronary artery disease cases escalate due to factors such as smoking, excessive alcohol consumption, and sedentary habits, there is an increasing demand for advanced interventional solutions. These devices enable cardiologists to conduct minimally invasive procedures, enhancing patient outcomes and reducing complications. The focus on rapid and effective treatment options is driving innovation in device technology, positioning the market for robust expansion as healthcare systems prioritize efficient cardiovascular care to address the rising burden of heart-related ailments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Interventional Cardiology Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Coronary Stents
  • Bare-Metal Stent (Bms)
  • Drug-Eluting Stent (Des)
  • Others
• Structural Heart Devices
  • Heart Valves
  • Occluders & Others
• Angioplasty Balloons
• Catheters
  • Diagnostic Catheters
  • Angiography
  • Ivus
  • Treatment Catheters
  • Atherectomy
  • Thrombectomy
  • Ablation
• Embolic Protection Devices

Global Interventional Cardiology Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Ascs
• Catheterization Labs & Others

Global Interventional Cardiology Devices Market Size & CAGR (2026-2033)

• North America (Product, End User)
  • USA
  • Canada
• Europe (Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosensors International Group Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACIST Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Therapeutics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genetesis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMed Medical Instruments GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrbusNeich Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations